Larvol Delta - Carina-Biotech-to-Present-Details-of-Planned-Phase-12a-Clinical-Trial-of-LGR5Targeted-CART-Cell-Therapy-Candidate-CNA3103-for-Metastatic-Colorectal-Cancer-at-2023-ASCO-Annual-Meeting

CNA3103 - Carina Biotech

https://www.globenewswire.com/news-release/2023/05/01/2658632/0/en/Carina-Biotech-to-Present-Details-of-Planned-Phase-1-2a-Clinical-Trial-of-LGR5-Targeted-CAR-T-Cell-Therapy-Candidate-CNA3103-for-Metastatic-Colorectal-Cancer-at-2023-ASCO-Annual-Me.html

May 1, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next